Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02413853
Title Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
Acronym PRIMIER
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field